KAUST alumnus Fahad Hossain (M.S. 2010, Ph.D. 2014) discusses his journey from KAUST to UC Berkeley, where he co-founded Serinus Labs Inc., a manufacturer of integrated silicon gas sensors. Serinus Labs develops gas-sensing solutions for air-quality monitoring, safety, and preventive healthcare. NASA became Serinus' first customer in 2018, contracting them to develop multi-gas sensors for the next generation of spacesuits. Why it matters: This highlights the impact of KAUST graduates in developing advanced sensor technologies and securing partnerships with leading organizations like NASA.
KAUST's Bioscience Core Lab (BCL) supports regional and global health initiatives through industry partnerships, offering expertise and technology access to organizations like SaudiVax. BCL aids SaudiVax in developing vaccines and monoclonal antibodies tailored to the needs of Saudi Arabia and the MENA region, focusing on respiratory diseases like MERS and COVID-19. SaudiVax is also collaborating with KAUST to research a new preventative drug targeting SARS-CoV-2. Why it matters: This strengthens Saudi Arabia's capabilities in vaccine development and biomanufacturing, addressing critical healthcare needs in the region and reducing reliance on external sources.
KAUST researchers are developing a streamlined COVID-19 diagnostic testing method using superparamagnetic nanoparticles (MNPs). The team, led by Assistant Professor Mo Li, aims to address reagent shortages and improve automation by creating an in-house extraction kit compatible with inactivated samples. Associate Professor Samir Hamdan identified a protocol for making silica-coated MNPs that survive inactivation reagents, enabling magnetic separation without centrifugation. Why it matters: This innovation could significantly increase testing capacity in Saudi Arabia and globally by reducing biosafety risks, reagent dependence, and manual processing.
KAUST and KACST have partnered to assess the safety of seafood from the Red Sea and Arabian Gulf, with KACST funding an environmental contaminants lab at KAUST. Researchers from KAUST's Coastal & Marine Resources Core Lab (CMR) collect samples, which are then analyzed by the Analytical Chemistry Core Lab (ACL). The project aims to determine the exposure status of the Saudi population to environmental contaminants and provide recommendations on safe seafood consumption. Why it matters: Ensuring the safety of consumable fishery products is crucial for public health and food security in Saudi Arabia.
Sahika Inal is an assistant professor of bioscience at KAUST's Biological and Environmental Science and Engineering Division. She is a faculty member at King Abdullah University of Science and Technology. Why it matters: This highlights KAUST's ongoing investment in attracting research talent in bioscience.
KAUST's Rapid Research Response Team (R3T), including Professor Samir Hamdan, is working to understand and counteract the spread of COVID-19. The team assembled a complete homemade, one-step RT-PCR test, comparable to commercial kits, with a patent-free manufacturing recipe. KAUST R3T is also researching faster, more accurate point-of-care tests, including a CRISPR-based molecular test. Why it matters: This research provides accessible testing solutions and contributes to more effective and rapid detection methods for combating viral spread in the region and globally.
KAUST held its first bio-entrepreneurship ideation workshop, "Ignite Bio", for Biological and Environmental Science and Engineering students and postdoctoral fellows. Speakers from Noor Diagnostics and Discovery, Cellestia BioTech, Kyanos Biotechnology and SaudiVax shared their experiences about the startup journey. Saudi-based startups highlighted the need for services and products not currently available in the Kingdom, such as genetic diagnostic testing and local vaccine production. Why it matters: The workshop and the highlighted startups signal growing interest and opportunities for biotech innovation and entrepreneurship within Saudi Arabia.
KAUST and King Faisal Specialist Hospital and Research Centre (KFSH&RC) are collaborating to develop bioelectronic sensors for rapid pathogen detection. These sensors aim to provide cheap and accurate results, potentially replacing conventional lab tests. A COVID-19 saliva test developed by KAUST researchers showed comparable sensitivity to PCR tests with a 15-minute turnaround. Why it matters: This partnership accelerates the development of novel diagnostic tools, which could improve healthcare accessibility in remote areas and low-income countries within the region.